COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing
Coeptis (Nasdaq: COEP) has announced a strategic partnership between its NexGenAI Affiliates Network and MarketLeverage, combining AI technology with performance-based marketing strategies. The collaboration provides access to MarketLeverage's network of 5,500 advertisers and 55,000 publishers, creating one of the industry's most extensive affiliate networks.
The partnership integrates AI-driven campaign management, predictive analytics, and automated outreach capabilities. Affiliates will earn commissions through automated content distribution, social media sharing, and targeted email campaigns, with AI optimizing performance in real-time.
The artificial intelligence marketing market is projected to grow from $27.83 billion in 2024 to $106.54 billion in 2029, with a CAGR of 31.6%.
Coeptis (Nasdaq: COEP) ha annunciato una partnership strategica tra la sua NexGenAI Affiliates Network e MarketLeverage, combinando la tecnologia AI con strategie di marketing basate sulle performance. Questa collaborazione offre accesso alla rete di MarketLeverage composta da 5.500 inserzionisti e 55.000 editori, creando una delle reti affiliate più estese del settore.
La partnership integra la gestione delle campagne guidata dall'AI, l'analisi predittiva e le capacità di outreach automatizzate. Gli affiliati guadagneranno commissioni attraverso la distribuzione automatizzata dei contenuti, la condivisione sui social media e campagne email mirate, con l'AI che ottimizza le performance in tempo reale.
Il mercato del marketing basato sull'intelligenza artificiale è previsto crescere da 27,83 miliardi di dollari nel 2024 a 106,54 miliardi di dollari nel 2029, con un tasso di crescita annuale composto (CAGR) del 31,6%.
Coeptis (Nasdaq: COEP) ha anunciado una asociación estratégica entre su NexGenAI Affiliates Network y MarketLeverage, combinando la tecnología de IA con estrategias de marketing basadas en el rendimiento. Esta colaboración ofrece acceso a la red de MarketLeverage que cuenta con 5,500 anunciantes y 55,000 editores, creando una de las redes de afiliados más extensas de la industria.
La asociación integra la gestión de campañas impulsada por IA, analítica predictiva y capacidades de divulgación automatizada. Los afiliados ganarán comisiones a través de la distribución automatizada de contenido, el uso compartido en redes sociales y campañas de correo electrónico dirigidas, con la IA optimizando el rendimiento en tiempo real.
Se proyecta que el mercado de marketing basado en inteligencia artificial crezca de 27.83 mil millones de dólares en 2024 a 106.54 mil millones de dólares en 2029, con una tasa de crecimiento anual compuesta (CAGR) del 31.6%.
Coeptis (Nasdaq: COEP)는 NexGenAI Affiliates Network와 MarketLeverage 간의 전략적 파트너십을 발표했습니다. 이는 AI 기술과 성과 기반 마케팅 전략을 결합한 것입니다. 이 협력은 MarketLeverage의 5,500 광고주 및 55,000 퍼블리셔 네트워크에 접근할 수 있게 하여 업계에서 가장 광범위한 제휴 네트워크 중 하나를 만듭니다.
이 파트너십은 AI 기반 캠페인 관리, 예측 분석 및 자동화된 아웃리치 기능을 통합합니다. 제휴사들은 자동화된 콘텐츠 배포, 소셜 미디어 공유 및 타겟 이메일 캠페인을 통해 커미션을 벌며, AI가 실시간으로 성과를 최적화합니다.
인공지능 마케팅 시장은 2024년 278억 3천만 달러에서 2029년 1,065억 4천만 달러로 성장할 것으로 예상되며, 연평균 성장률(CAGR)은 31.6%입니다.
Coeptis (Nasdaq: COEP) a annoncé un partenariat stratégique entre son NexGenAI Affiliates Network et MarketLeverage, alliant la technologie IA à des stratégies de marketing basées sur la performance. Cette collaboration permet d'accéder au réseau de MarketLeverage, qui compte 5 500 annonceurs et 55 000 éditeurs, créant ainsi l'un des réseaux d'affiliation les plus étendus du secteur.
Le partenariat intègre la gestion de campagnes pilotée par IA, l'analyse prédictive et des capacités de sensibilisation automatisées. Les affiliés gagneront des commissions grâce à la distribution automatique de contenu, au partage sur les réseaux sociaux et aux campagnes par e-mail ciblées, avec l'IA optimisant les performances en temps réel.
Le marché du marketing basé sur l'intelligence artificielle devrait passer de 27,83 milliards de dollars en 2024 à 106,54 milliards de dollars en 2029, avec un taux de croissance annuel composé (CAGR) de 31,6%.
Coeptis (Nasdaq: COEP) hat eine strategische Partnerschaft zwischen seinem NexGenAI Affiliates Network und MarketLeverage bekannt gegeben, die KI-Technologie mit leistungsbasierten Marketingstrategien kombiniert. Diese Zusammenarbeit bietet Zugang zum Netzwerk von MarketLeverage mit 5.500 Werbetreibenden und 55.000 Publishern und schafft eines der umfangreichsten Affiliate-Netzwerke der Branche.
Die Partnerschaft integriert KI-gesteuertes Kampagnenmanagement, prädiktive Analysen und automatisierte Outreach-Funktionen. Affiliates verdienen Provisionen durch automatisierte Inhaltsverteilung, Social-Media-Sharing und gezielte E-Mail-Kampagnen, während die KI die Leistung in Echtzeit optimiert.
Der Markt für KI-gestütztes Marketing wird voraussichtlich von 27,83 Milliarden USD im Jahr 2024 auf 106,54 Milliarden USD im Jahr 2029 wachsen, mit einer jährlichen Wachstumsrate (CAGR) von 31,6%.
- Access to MarketLeverage's extensive network of 5,500 advertisers and 55,000 publishers
- Entry into the rapidly growing AI marketing market (CAGR 31.6% through 2029)
- Integration of AI-driven automation tools for improved marketing efficiency
- None.
Insights
This strategic partnership marks a pivotal transformation for COEPTIS, signaling a significant diversification from its traditional biotechnology focus into the high-growth AI marketing technology sector. The integration with MarketLeverage's extensive network creates immediate scale, providing access to 5,500 advertisers and 55,000 publishers, which could accelerate revenue generation through commission-based earnings.
The partnership's value proposition centers on three key technological advantages:
- AI-driven campaign optimization that can potentially reduce customer acquisition costs and improve ROI for advertisers
- Automated content distribution systems that can scale affiliate marketing efforts without proportional increase in operational costs
- Predictive analytics capabilities that could create competitive barriers through superior targeting and conversion optimization
The market timing is particularly strategic, as the AI marketing sector is projected to grow at a CAGR of
However, several critical factors warrant attention:
- The integration complexity between COEPTIS's AI technology and MarketLeverage's existing infrastructure could impact initial deployment timelines
- The competitive landscape in AI marketing is intensifying, with established tech giants and startups vying for market share
- Success will largely depend on the platform's ability to demonstrate measurable ROI improvements for advertisers and publishers
While the partnership presents compelling growth potential, the execution of this strategic pivot will be crucial. The ability to leverage MarketLeverage's established network while successfully integrating and scaling AI capabilities will determine the long-term value creation for COEPTIS shareholders.
This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage’s 5,500 advertisers and 55,000 publishers, creating one of the most expansive and effective affiliate networks in the industry
WEXFORD, Pa., Feb. 19, 2025 (GLOBE NEWSWIRE) -- COEPTIS, Inc. (Nasdaq: COEP) ("the Company" or "Coeptis"), a pioneering technology firm at the forefront of innovative biotechnology solutions, is thrilled to announce a partnership between COEPTIS’ NexGenAI Affiliates Network and MarketLeverage, a leading digital advertising firm and affiliate network. This collaboration aims to redefine affiliate marketing by integrating cutting-edge AI technology with performance-based strategies.
With MarketLeverage’s extensive industry expertise and NexGenAI Affiliates Network’s innovative AI-powered platform, this collaboration will empower affiliates, brands, and marketers with advanced automation, data-driven insights, and seamless campaign optimization. MarketLeverage currently works with 5,500 advertisers and 55,000 publishers, creating one of the most expansive and effective affiliate networks in the industry. This strategic partnership will drive high-quality traffic, increase conversions, and enhance overall marketing efficiency.
“This partnership marks a significant step in transforming digital marketing by integrating AI with performance-based strategies,” said Shane Hackett, CEO of MarketLeverage. “By combining our extensive network of advertisers and affiliates with NexGenAI’s automated tools, we will provide businesses with unprecedented opportunities to scale their marketing efforts. The future of affiliate marketing is in automation and AI-driven insights, and we are excited to lead this transformation.”
NexGenAI Affiliates Network, recently acquired by Coeptis Therapeutics Holdings Inc., has quickly established itself as a leader in AI-powered marketing automation. The platform enables affiliates to earn commissions through automated content distribution, social media sharing, and targeted email campaigns, leveraging AI to optimize performance in real-time.
“Our mission has always been to empower marketers with the latest AI-driven solutions,” said Dave Mehalick, CEO of Coeptis Therapeutics Holdings Inc. “Partnering with MarketLeverage will accelerate our reach and provide affiliates and brands with an unmatched ability to monetize digital content and drive engagement. With MarketLeverage’s vast network and our AI-powered tools, we are creating a new frontier in performance marketing.”
Through this collaboration, affiliates will gain access to an enhanced suite of tools, including AI-driven campaign management, predictive analytics, and automated outreach capabilities. Advertisers will benefit from increased visibility, higher conversion rates, and improved return on investment.
The partnership between MarketLeverage and NexGenAI Affiliates Network underscores a shared commitment to innovation and efficiency in the digital marketing space. As AI continues to shape the future of affiliate marketing, this alliance ensures that brands, affiliates, and publishers stay ahead of the curve. As COEPTIS has entered the artificial intelligence marketplace, the market size will grow from
For more information on this partnership and how it can benefit businesses and affiliates, visit https://www.marketleverage.com/ and https://nexgenaiaffiliates.io/.
About COEPTIS, Inc.
COEPTIS, Inc., together with its subsidiaries Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc., SNAP Biosciences, Inc., and Coeptis Technologies (collectively "Coeptis"), is a biopharmaceutical and technology company. The biopharmaceutical divisions focus on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its cutting-edge research and development efforts.
The Company's therapeutic portfolio is underscored by assets licensed from Deverra Therapeutics, which include an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. COEPTIS is also developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), alongside GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and distinguished medical researchers at the Karolinska Institute.
Building on its core competencies, COEPTIS has recently established a Technology Division, which focuses on enhancing operational capabilities through advanced technologies. This division features AI-powered marketing software and robotic process automation tools acquired from NexGenAI Solutions Group, designed to optimize business processes and improve overall efficiency.
Headquartered in Wexford, PA, COEPTIS is dedicated to advancing its mission within the regulatory framework set forth by the FDA, ensuring that all activities align with the highest standards of compliance and patient care. For more information on COEPTIS, visit https://coeptistx.com
About MarketLeverage
MarketLeverage is an award-winning digital advertising firm specializing in performance marketing and affiliate campaign management. With over two decades of experience, the company helps brands scale their digital presence through targeted lead generation and strategic partnerships. MarketLeverage has been recognized as an INC 100 Advertising Agency and among the Fortune 5000 Fastest Growing Private Companies. MarketLeverage currently works with 5,500 advertisers and 55,000 publishers to drive impactful marketing campaigns.
About NexGenAI Affiliates Network
NexGenAI Affiliates Network is a state-of-the-art AI-powered affiliate marketing platform designed to streamline marketing efforts through automation and advanced analytics. Owned by Coeptis Therapeutics Holdings Inc., NexGenAI Affiliates Network empowers individuals and businesses to optimize their affiliate campaigns and maximize revenue through AI-driven content distribution, automated email outreach, and social media integration.
Cautionary Note Regarding Forward-Looking Statements
This press release and statements of our management made in connection therewith contain or may contain "forward-looking statements" (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended). Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events or performance, and underlying assumptions, and other statements that are other than statements of historical facts. When we use words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. Forward-looking statements are not a guarantee of future performance and involve significant risks and uncertainties that may cause the actual results to differ materially and perhaps substantially from our expectations discussed in the forward-looking statements. Factors that may cause such differences include but are not limited to: (1) the inability to maintain the listing of the Company's securities on the Nasdaq Capital Market; (2) the inability to recognize the anticipated benefits of the Deverra licensed assets, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth economically and hire and retain key employees; (3) the risks that the Company's products in development or the newly-licensed assets fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable regulatory authorities; (4) costs related to ongoing asset development including the Deverra licensed assets and pursuing the contemplated asset development paths; (5) changes in applicable laws or regulations; (6) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and (7) the impact of the global COVID-19 pandemic on any of the foregoing risks and other risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission (the "SEC"). The foregoing list of factors is not exclusive. All forward-looking statements are subject to significant uncertainties and risks including, but not limited, to those risks contained or to be contained in reports and other filings filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings made or to be made with the SEC, which are available for review at www.sec.gov. We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof unless required by applicable laws, regulations, or rules.
Contacts
IR@coeptistx.com
FAQ
What is the strategic partnership between COEP's NexGenAI and MarketLeverage?
How many advertisers and publishers does the COEP-MarketLeverage partnership reach?
What is the projected growth of the AI marketing market that COEP is entering?
What AI capabilities does the COEP-MarketLeverage partnership offer to affiliates?
